{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "To perform a double-blinded randomized study comparing 3 different doses of 5-ALA."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Twenty-one patients with suspected malignant glioma were randomly assigned to 0.2, 2, or 20 mg/kg 5-ALA."
      },
      "Participants": {
        "score": 1,
        "evidence": "Twenty-one patients with suspected malignant glioma"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to 0.2, 2, or 20 mg/kg 5-ALA."
      },
      "Objective": {
        "score": 1,
        "evidence": "OBJECTIVE: To perform a double-blinded randomized study comparing 3 different doses of 5-ALA."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Twenty-one patients with suspected malignant glioma were randomly assigned"
      },
      "Blinding": {
        "score": 2,
        "evidence": "double-blinded randomized study"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Twenty-one patients with suspected malignant glioma were randomly assigned"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "A 10-fold increase in 5-ALA dose (2-20 mg/kg) resulted in a 4-fold increase of fluorescence contrast"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}